Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Catalyst Pharmaceutical
Fierce Pharma
3 biopharma CEOs explain why they are 'authentically optimistic'
That was the consensus among leaders from three biopharma companies—Perspective, Lineage and Catalyst—who sat down with Fierce late last year.
Fraiser Kansteiner
Jan 6, 2026 11:54am
Protara gears up for next commercial steps—Chutes & Ladders
Jun 6, 2025 8:30am
BIO announces new CEO—Chutes & Ladders
Dec 8, 2023 9:30am
Pfizer exec out the door—Chutes & Ladders
Jul 28, 2023 9:30am
Santhera offloads North American rights for DMD med to Catalyst
Jun 20, 2023 9:53am
Catalyst to ax 30% of workforce in wake of FDA trial demands
May 17, 2016 9:10am
